So who to _老虎社区_美港股上老虎

2021-12-01

So who to believe !! BNTX says it will work on variant and MRNA say not ! lol...

either way NVAX is the answer !!.. come on make a comment again dive in and speak out !!

FRANKFURT — BioNTech and Pfizer's Covid-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant, BioNTech's Chief Executive told Reuters, as the firm weighs the need to upgrade its commonly used shot.

Lab tests are underway over the next two weeks to analyse the blood of people who had two or three doses of BioNTech's Comirnaty vaccine to see if antibodies found in that blood inactivate Omicron, shedding light on whether new vaccines are needed.

"We think it's likely that people will have substantial protection against severe disease caused by Omicron," said BioNTech CEO and co-founder Ugur Sahin. He specified severe disease as requiring hospital or$Novavax(NVAX)$ $BioNTech SE(BNTX)$ $Moderna, Inc.(MRNA)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":603009251,"tweetId":"603009251","gmtCreate":1638333687071,"gmtModify":1638337903416,"author":{"id":3479274726597090,"idStr":"3479274726597090","authorId":3479274726597090,"authorIdStr":"3479274726597090","name":"Leoopl","avatar":"https://static.laohu8.com/picture57","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":55,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>So who to believe !! BNTX says it will work on variant and MRNA say not ! lol... either way NVAX is the answer !!.. come on make a comment again dive in and speak out !! FRANKFURT — BioNTech and Pfizer's Covid-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant, BioNTech's Chief Executive told Reuters, as the firm weighs the need to upgrade its commonly used shot. Lab tests are underway over the next two weeks to analyse the blood of people who had two or three doses of BioNTech's Comirnaty vaccine to see if antibodies found in that blood inactivate Omicron, shedding light on whether new vaccines are needed. \"We think it's likely that people will have substantial protection against severe disease caused by Omicron,\" said BioNTech CEO and co-founder Ugur Sahin. He specified severe disease as requiring hospital or<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a> <a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a> <a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> </body></html>","htmlText":"<html><head></head><body>So who to believe !! BNTX says it will work on variant and MRNA say not ! lol... either way NVAX is the answer !!.. come on make a comment again dive in and speak out !! FRANKFURT — BioNTech and Pfizer's Covid-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant, BioNTech's Chief Executive told Reuters, as the firm weighs the need to upgrade its commonly used shot. Lab tests are underway over the next two weeks to analyse the blood of people who had two or three doses of BioNTech's Comirnaty vaccine to see if antibodies found in that blood inactivate Omicron, shedding light on whether new vaccines are needed. \"We think it's likely that people will have substantial protection against severe disease caused by Omicron,\" said BioNTech CEO and co-founder Ugur Sahin. He specified severe disease as requiring hospital or<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a> <a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a> <a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> </body></html>","text":"So who to believe !! BNTX says it will work on variant and MRNA say not ! lol... either way NVAX is the answer !!.. come on make a comment again dive in and speak out !! FRANKFURT — BioNTech and Pfizer's Covid-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant, BioNTech's Chief Executive told Reuters, as the firm weighs the need to upgrade its commonly used shot. Lab tests are underway over the next two weeks to analyse the blood of people who had two or three doses of BioNTech's Comirnaty vaccine to see if antibodies found in that blood inactivate Omicron, shedding light on whether new vaccines are needed. \"We think it's likely that people will have substantial protection against severe disease caused by Omicron,\" said BioNTech CEO and co-founder Ugur Sahin. He specified severe disease as requiring hospital or$Novavax(NVAX)$ $BioNTech SE(BNTX)$ $Moderna, Inc.(MRNA)$","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/603009251","repostId":0,"isVote":1,"tweetType":1,"viewCount":2233,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BNTX","NVAX","MRNA"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":784,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/603009251"}